Company Opiant Pharmaceuticals, Inc.
Equities
OPNT
US6837501039
Biotechnology & Medical Research
Business Summary
Number of employees: 38
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ryan Preblick
DFI | Director of Finance/CFO | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,268,677 | 4,860,817 ( 92.26 %) | 0 | 92.26 % |
Company contact information
Opiant Pharmaceuticals, Inc.
10710 Midlothian Turnpike Suite 125
23235, Richmond
+
https://www.opiant.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |